Spermidine,
does it really help with Reduction of telogen hair loss and prolongation of anagen?
research showsA human trial reported a higher proportion of anagen follicles with a spermidine-based supplement, but it was a single manufacturer-funded study in 100 healthy adults and focused on surrogate measures such as stages of plucked follicles and the hair-pull test. No independent RCT establishing clinical shedding or hair-density improvement in patients with telogen effluvium was identified, so the grade is C.
ads claimClaims such as 'activates autophagy for hair growth,' 'blocks telogen shedding,' and 'extends anagen' convert follicle-culture mechanisms and limited surrogate evidence into actual hair regrowth. Longevity or cognition research is not evidence for hair efficacy.
Useful facts when choosing a product
- Products sold online or imported into South Korea use wheat-germ-derived or high-purity spermidine and vary in labeled dose.
- The key hair RCT used one tablet daily, but the actual spermidine dose and full composition were not clearly reported in the paper.
- A combination supplement or wheat-germ product is not interchangeable with isolated spermidine.
Chamgap Semantic Classification Code
Candidate index · review held
S.spermidine.UNK.telogen-hair-loss-and-prolongation-of-anagen.reduce.placeboSupplements and nutraceuticals > Spermidine > Unknown > telogen hair loss and prolongation of anagen > Reduction claim > Placebo
An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.
What the research actually shows
Rinaldi 2017 assigned 100 healthy adults to a supplement or placebo for 90 days and assessed anagen stages in 100 plucked follicles, Ki-67, c-Kit, and the hair-pull test. Some outcomes improved, but Giuliani fully funded the study and authors included employees and a consultant. Ramot 2011 and Parodi 2018 studied growth and autophagy in ex vivo human scalp follicles; neither was a clinical trial of oral spermidine alone for hair loss.
Why this is classified as C (44)
A randomized human trial exists, but the healthy population, surrogate outcomes, and single manufacturer-linked product limit the grade to C with 44 points.
Counterpoint. The anagen-follicle signal justifies independent follow-up trials but does not confirm clinical improvement of hair loss.
Rejudgment record. New verdict — A human RCT exists, but healthy-participant surrogate outcomes, one manufacturer-linked product, and no clinical hair-loss endpoint limit it to C
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Prolongation of the anagen phase | C | The signal comes from the proportion of plucked anagen follicles in one RCT of healthy adults. |
| Reduction of telogen hair loss | C | A hair-pull signal exists, but there is no hair-count or density RCT in diagnosed telogen effluvium. |
Cross-check — AI research and Codex final gate
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Rinaldi F et al. 2017 | Randomized, double-blind, placebo-controlled, single-center trial | 100 | Fully funded by Giuliani; employee and consultant authors | Anagen stage of plucked follicles, Ki-67, c-Kit, and hair-pull test | The proportion of anagen follicles and some markers improved after 90 days; there was no clinical hair-count or density endpoint. | Key |
| Ramot Y et al. 2011 | Ex vivo human scalp-hair-follicle study | Partly funded by Giuliani with disclosed conflicts | Hair-shaft growth, anagen, and epithelial stem-cell markers | Low concentrations of spermidine produced a follicle-growth signal; this was not an oral human trial. | Mechanistic | |
| Parodi C et al. 2018 | Human scalp-hair-follicle organ-culture mechanistic study | Product-related collaboration | Autophagy activity and maintenance of anagen | Autophagy was involved in maintaining follicle growth, but clinical hair-growth efficacy was not tested. | Mechanistic |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-07-17).
Final verification and publication gate: Codex · Evidence date: 2026-07-17 · Corrections: none
Cite this verdict
[Chamgap] Spermidine x reduction of telogen hair loss and prolongation of anagen — Evidence Grade C·44. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/skin-hair/spermidine-hair-growth-anagen/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.